Target intelligence / Profile preview

Chikungunya virus non-structural polyprotein (CHIKV nsP)

Target
CHIKV nsP
Molecular classification
Enzyme, RNA-dependent RNA polymerase, Cysteine protease, Helicase, Methyltransferase
01

Overview

The Chikungunya virus (CHIKV) replication machinery is a multi-protein complex derived from the non-structural polyprotein, which is cleaved into four essential subunits: nsP1, nsP2, nsP3, and nsP4 (UniProt: P0C2P5). This complex is responsible for the synthesis of viral genomic and subgenomic RNA within the host cell cytoplasm (PubMed: 32824354). nsP1 is involved in RNA capping and membrane anchoring, nsP2 acts as a protease and helicase, nsP3 facilitates host-protein interactions, and nsP4 serves as the primary RNA-dependent RNA polymerase (PubMed: 29456131). As these enzymes are critical for viral survival and lack human orthologs, they represent high-value therapeutic targets for treating Chikungunya fever (NCBI: NBK537333). Current drug discovery efforts target these proteins to inhibit viral load and alleviate the debilitating joint pain associated with infection (PubMed: 31433746).

Other names
Chikungunya virus replication complexCHIKV nsP1-4Chikungunya virus non-structural proteinsCHIKV replicase
02

Mechanism of action

Inhibition of viral RNA-dependent RNA polymerase (RdRp) activity, inhibition of nsP2 protease-mediated polyprotein cleavage, or interference with nsP1-mediated RNA capping (PubMed: 29456131).

03

Biological functions

Viral RNA replicationPolyprotein processingRNA cappingHost-virus interaction
04

Disease associations

InfectionChikungunya feverArthralgia
05

Safety considerations

Potential for viral resistance mutations (PubMed: 29456131)Off-target inhibition of host cellular polymerasesTeratogenicity associated with nucleoside analogs like Ribavirin (StatPearls: NBK513349)
06

Interacting drugs

Ribavirin (PubMed: 21148252)

4 more in the full profile.

07

Biomarkers

Viral RNA titer (RT-qPCR)CHIKV nsP1-4 protein levelsPlaque reduction neutralization test (PRNT)

Beyond the preview

Go deeper on Chikungunya virus non-structural polyprotein (CHIKV nsP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chikungunya virus non-structural polyprotein (CHIKV nsP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call